Shire plc appointed Andreas Busch executive vice president, head of research and development and chief scientific officer.
Howard Mayer, who is serving as interim head of R&D, was appointed chief medical officer.
Both appointments are effective January 2018.
Busch previously served as head of drug discovery of Bayer AG's pharmaceutical division.
